All News about Tcr2 Therapeutics Inc
Where TCR2 Therapeutics Stands With Analysts
January 06, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
From TCR2 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
TCR² Therapeutics Announces Pipeline Priorities for 2023
January 05, 2023
From TCR2 Therapeutics
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23692.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_19488.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/28/aapharma_3.png?width=1200&height=800&fit=crop)
TCR2 Therapeutics Shares Jump After Additional Reponses in Ovarian Cancer, Mesothelioma
September 28, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_330.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23992.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23815.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23623.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Thursday
December 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23351.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Monday
December 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23526.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Wednesday
December 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23260.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Friday
December 09, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
From TCR2 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
TCR² Therapeutics to Present at the Piper Sandler Healthcare Conference
November 23, 2022
From TCR2 Therapeutics
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/11/21/image-procter__gamble.jpg?width=1200&height=800&fit=crop)
Procter & Gamble To Jump Over 16%? Here Are 5 Other Price Target Changes For Monday
November 21, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21043.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
From TCR2 Therapeutics
Via GlobeNewswire
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
From TCR2 Therapeutics
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_17942.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/0de74528-9856-4063-8961-ce8c73f5ab44/small/tcr2-brand-logo-cmyk-fullcolor-042921-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_9380.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_6805.jpeg)
![](https://cdn.benzinga.com/files/images/story/2012/price_targets_405.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_4871.jpeg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.